Targeting KRAS: Pre-Clinical Validation & Therapeutic Perspectives to Overcome Drug Resistance

Time: 1:30 pm
day: Day One Track B

Details:

  • New biomarker needed to predict sensitivity to direct KRAS inhibitors
  • Acquired versus adaptive mechanisms of resistance to G12C inhibitors
  • Novel therapeutic strategies to overcome resistance

Speakers: